News Focus
News Focus
Followers 0
Posts 1
Boards Moderated 0
Alias Born 03/26/2023

Re: None

Tuesday, 04/04/2023 9:30:46 AM

Tuesday, April 04, 2023 9:30:46 AM

Post# of 404752
LadRx Announces Receipt of $75 Million Milestone Payment from ImmunityBio

LOS ANGELES--(BUSINESS WIRE)--LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, announced today that it has received $75 million payment under the license agreement with ImmunityBio.

www.ladrx.com

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today